Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients

In 2005 the WHO introduced the former odontogenic keratocyst to the category of benign odontogenic tumours. The change in terminology was based on the observation that the odontogenic keratocyst behaves as a neoplasm and not like a benign cystic lesion. The present paper is a retrospective analysis...

Full description

Bibliographic Details
Main Authors: A. Cassoni, V. Valentini, M. Della Monaca, M. Pagnoni, G.M. Prucher, E. Brauner, G. Guarino, M.T. Fadda, S. Jamshir, G. Pompa, G. Iannetti
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1401200123
_version_ 1818234055594868736
author A. Cassoni
V. Valentini
M. Della Monaca
M. Pagnoni
G.M. Prucher
E. Brauner
G. Guarino
M.T. Fadda
S. Jamshir
G. Pompa
G. Iannetti
author_facet A. Cassoni
V. Valentini
M. Della Monaca
M. Pagnoni
G.M. Prucher
E. Brauner
G. Guarino
M.T. Fadda
S. Jamshir
G. Pompa
G. Iannetti
author_sort A. Cassoni
collection DOAJ
description In 2005 the WHO introduced the former odontogenic keratocyst to the category of benign odontogenic tumours. The change in terminology was based on the observation that the odontogenic keratocyst behaves as a neoplasm and not like a benign cystic lesion. The present paper is a retrospective analysis on the management of keratocystic odontogenic tumor over a period of 11 years (2001–2012) in the Department of Maxillo-Facial Surgery at the University of Rome “Sapienza”, with particular focus on the surgical choices and the relative rates of relapse. The patient population consisted of 34 females and 43 males. Administered treatment modalities consisted of enucleation in 55 cases and radical resection in 22 cases. Nineteen percent of patients who underwent enucleation suffered KCOT relapse. No relapse was observed in the radical resection group with follow-up of 3–7 years. The goals of the treatment include elimination of the pathology and decrease of potential recurrence while minimizing harm to the patient. In the Authors' experience, conservative treatment still encompasses a high rate of recurrence; otherwise, resection provides the lowest recurrence rate, yet causes the most suffering to the patient. The issue surgeons encounter is whether to choose a conservative approach, reducing the morbidity to the patient, knowing that several operations may be required to eliminate recurrence; or being more aggressive and potentially more destructive, at the same time ensuring the best condition to avoid recurrence. Other studies are needed in order to find definitive guidelines for this challenging pathology.
first_indexed 2024-12-12T11:32:00Z
format Article
id doaj.art-522d6455869449feabb23a7ef15a6449
institution Directory Open Access Journal
issn 1721-727X
language English
last_indexed 2024-12-12T11:32:00Z
publishDate 2014-01-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-522d6455869449feabb23a7ef15a64492022-12-22T00:25:46ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2014-01-011210.1177/1721727X1401200123Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 PatientsA. CassoniV. ValentiniM. Della MonacaM. PagnoniG.M. PrucherE. BraunerG. GuarinoM.T. FaddaS. JamshirG. PompaG. IannettiIn 2005 the WHO introduced the former odontogenic keratocyst to the category of benign odontogenic tumours. The change in terminology was based on the observation that the odontogenic keratocyst behaves as a neoplasm and not like a benign cystic lesion. The present paper is a retrospective analysis on the management of keratocystic odontogenic tumor over a period of 11 years (2001–2012) in the Department of Maxillo-Facial Surgery at the University of Rome “Sapienza”, with particular focus on the surgical choices and the relative rates of relapse. The patient population consisted of 34 females and 43 males. Administered treatment modalities consisted of enucleation in 55 cases and radical resection in 22 cases. Nineteen percent of patients who underwent enucleation suffered KCOT relapse. No relapse was observed in the radical resection group with follow-up of 3–7 years. The goals of the treatment include elimination of the pathology and decrease of potential recurrence while minimizing harm to the patient. In the Authors' experience, conservative treatment still encompasses a high rate of recurrence; otherwise, resection provides the lowest recurrence rate, yet causes the most suffering to the patient. The issue surgeons encounter is whether to choose a conservative approach, reducing the morbidity to the patient, knowing that several operations may be required to eliminate recurrence; or being more aggressive and potentially more destructive, at the same time ensuring the best condition to avoid recurrence. Other studies are needed in order to find definitive guidelines for this challenging pathology.https://doi.org/10.1177/1721727X1401200123
spellingShingle A. Cassoni
V. Valentini
M. Della Monaca
M. Pagnoni
G.M. Prucher
E. Brauner
G. Guarino
M.T. Fadda
S. Jamshir
G. Pompa
G. Iannetti
Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
European Journal of Inflammation
title Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
title_full Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
title_fullStr Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
title_full_unstemmed Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
title_short Keratocystic Odontogenic Tumor Surgical Management: Retrospective Analysis on 77 Patients
title_sort keratocystic odontogenic tumor surgical management retrospective analysis on 77 patients
url https://doi.org/10.1177/1721727X1401200123
work_keys_str_mv AT acassoni keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT vvalentini keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT mdellamonaca keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT mpagnoni keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT gmprucher keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT ebrauner keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT gguarino keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT mtfadda keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT sjamshir keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT gpompa keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients
AT giannetti keratocysticodontogenictumorsurgicalmanagementretrospectiveanalysison77patients